Evidence map›Paper›PMID 30576001›Full record

ArticleJournal of leukocyte biology2019

Frontline Science: A reduction in DHA-derived mediators in male obesity contributes toward defects in select B cell subsets and circulating antibody.

Miranda J Crouch, Rasagna Kosaraju, William Guesdon, Michael Armstrong, Nichole Reisdorph, Raghav Jain, Jenifer Fenton, Saame Raza Shaikh

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04701138 (Bioavailability of Specialized Pro-resolving Mediators in Obese Humans), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04701138 nacompletednot on this mapstarted 2021, after this paper: background citation

Bioavailability of Specialized Pro-resolving Mediators in Obese Humans

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2021 to 2021Enrolled24ConditionsObesity Adult OnsetArmsSPM Active
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Scd-1 deficiency promotes the differentiation of CD8Frontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass-dependent therapeutic window for resolvin E1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Miranda J CrouchDepartment of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Rasagna KosarajuDepartment of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
William GuesdonDepartment of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Michael ArmstrongDepartment of Pharmaceutical Sciences, University of Colorado, Denver, Colorado, USA.
Nichole ReisdorphDepartment of Pharmaceutical Sciences, University of Colorado, Denver, Colorado, USA.
Raghav JainThe College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA.
Jenifer FentonThe College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA.
Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
East Carolina University · USMichigan State University · USUniversity of Colorado Denver · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
Suppressing inflammation and boosting humoral immunity with n-3 PUFAsR01AT008375 · NCCIH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAIKH, SAAME R · 2015 to 2019
$1.9M
Olympus Fluoview 1000 Confocal MicroscopeS10RR023622 · NCRR · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI FORREST, JOHN N · 2007 to 2007
$363k
NCATS NIH HHS UL1 TR001082NCCIH NIH HHS R01 AT008375NCI NIH HHS P30 CA016086NCRR NIH HHS S10 RR023622NIDDK NIH HHS P30 DK056350
6 · The paper itself

Abstract

Obesity dysregulates B cell populations, which contributes toward poor immunological outcomes. We previously reported that differing B cell subsets are lowered in the bone marrow of obese male mice. Here, we focused on how lipid metabolites synthesized from docosahexaenoic acid (DHA) known as specialized pro-resolving lipid mediators (SPMs) influence specific B cell populations in obese male mice. Metabololipidomics revealed that splenic SPM precursors 14-hydroxydocosahexaenoic acid (14-HDHA), 17-hydroxydocosahexaenoic acid (17-HDHA), and downstream protectin DX (PDX) were decreased in obese male C57BL/6J mice. Simultaneous administration of these mediators to obese mice rescued major decrements in bone marrow B cells, modest impairments in the spleen, and circulating IgG2c, which is pro-inflammatory in obesity. In vitro studies with B cells, flow cytometry experiments with ALOX5

Indexed as

AnimalsAntibodiesBiomarkersB-Lymphocyte SubsetsBone Marrow CellsDiet, High-FatDisease Models, AnimalDisease SusceptibilityDocosahexaenoic AcidsFemaleGerminal CenterHumansImmunophenotypingInflammation MediatorsLipid MetabolismLymphocyte Activation14-hydroxydocosahexaenoic acid17-hydroxy-4,7,10,13,15,19-docosahexaenoic acidAntibodiesBiomarkersDocosahexaenoic AcidsInflammation Mediators14-HDHA17-HDHAn-3 polyunsaturated fatty acidsPDX

Identifiers

PMID30576001
PMCPMC10020993
OpenAlexW2905866874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.